With a PhD and a Postdoc in organic chemistry, she gained experience in drug discovery, working as medicinal chemist at Actelion (biopharmaceutical company, Switzerland) and Sygnature Discovery (CRO, UK). After several years, she transferred to the DMPK department where she specialised on metabolite identification and reactive metabolites screening. She joined the Translational Science in DMPK team at Certara Predictive Technologies in January 2022.